Skip to main content

LAZARD ASSET MANAGEMENT LLC

Position in GH — Guardant Health, Inc.

CIK 1207017 NEW YORK, NY

Position in GH

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,175,384
+$919,801 QoQ
Shares Held
21,165
-13.3% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#221
of 593 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GH Over Time

Shares Held

Position Value (USD)

Derivatives in GH

reported options exposure · as of Mar 31, 2026
CallValue
$4,156,650
CallShares
45,000
PutValue
$3,325,320
PutShares
36,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

LAZARD ASSET MANAGEMENT LLC holds $1,362,821,685 across 21 Diagnostics & Research names. GH ranks #13 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in GH

Export CSV
28 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,175,384 21,165
2026-03-31 $3,325,320 36,000
2026-03-31 $2,255,583 24,419
2026-03-31 $4,156,650 45,000
2025-12-31 $7,762,640 76,000
2025-12-31 $3,123,951 30,585
2025-12-31 $9,703,300 95,000
2025-09-30 $3,155,864 50,510
2025-06-30 $1,543,246 29,655
2025-03-31 $1,312,335 30,806
2024-12-31 $1,516,227 49,631
2024-09-30 $2,735,617 119,251
2024-06-30 $3,935,448 136,269
2024-03-31 $2,842,133 137,767
2023-12-31 $4,061,205 150,137
2023-09-30 $4,632,465 156,291
2023-06-30 $7,039,031 196,621
2023-03-31 $4,613,413 196,818
2022-12-31 $4,190,622 154,067
2022-09-30 $11,751,680 218,311
2022-06-30 $8,476,562 210,128
2022-03-31 $7,301,965 110,235
2021-12-31 $8,403,480 84,018
2021-09-30 $5,120,909 40,964
2021-06-30 $4,127,453 33,235
2021-03-31 $79,072 518
2020-12-31 $75,523 586
2020-06-30 $3,813 47